Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|December 2, 2011
Discovery and bioactivity of 4-(2-arylpyrido[3',2':3,4]pyrrolo[1,2-f][1,2,4]triazin-4-yl) morpholine derivatives as novel PI3K inhibitorsJia Wang, Xiang Wang, Yanhong Chen, et al.Journal of Applied Biomaterials & Functional Materials|July 2, 2021
Effect of flushing temperature on preparation ability of rotary nickel-titanium filesGuangquan Chai, Ziyan Guo, Yingdi Wang, et al.Journal of Applied Biomaterials & Functional Materials|January 29, 2021
Effect of synchronous irrigation on cyclic fatigue of nickel-titanium instrument in the dynamic and static modelsHaiyun Liu, Yanfeng Li, Guangquan Chai, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2025
Decoding the Implications of Zinc in the Development and Therapy of LeukemiaBo Zhu, Chunhao Yang, Siqi Hua, et al.BMC Oral Health|May 18, 2026
Root-oriented replantation with socket reconstruction as a regenerative strategy for periodontally hopeless teeth: a pilot feasibility reportYingman Liu, Haoning Tang, Changjian Li, et al.European Journal of Medicinal Chemistry|January 17, 2018
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitorsXuxing Chen, Xiajuan Huan, Qiufeng Liu, et al.Journal of Medicinal Chemistry|September 7, 2021
Synthesis and Biological Evaluation of C-17-Amino-Substituted Pyrazole-Fused Betulinic Acid Derivatives as Novel Agents for Osteoarthritis TreatmentJie Wang, Wenhui Wei, Xiaofei Zhang, et al.Clinical and Translational Medicine|May 23, 2022
Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinomaHui Xing, Mengshi Gao, Yuxiang Wang, et al.Journal of Medicinal Chemistry|August 12, 2022
Development of an Orally Active Small-Molecule Inhibitor of Receptor Activator of Nuclear Factor-κB LigandKai Yang, Shunyao Li, Tianqi Wang, et al.Cancer Biology & Medicine|May 24, 2019
Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancerYuxiang Wang, Xian Li, Xueling Liu, et al.Pageof 9